SCHEMBL7146741

SCHEMBL7146741

Nc1nc(OCC=Cc2ccccc2)cc(-c2ccco2)n1

nearest known ligand 0.43

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 11/20 0.43
ADORA1 P30542 10/20 0.43
ADORA2B P29275 8/20 0.43
ADORA3 P0DMS8 7/20 0.43
ALDH1A1 P00352 2/20 0.42
NPC1 O15118 1/20 0.42
MAPK1 P28482 1/20 0.42
RAB9A P51151 1/20 0.42
MAPT P10636 2/20 0.42
TSHR P16473 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
GRM4 Q14833 1/20 0.39
IDO1 P14902 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7147989 0.79 NUDT1 (0.53) ADORA2AADORA1ADORA2BADORA3ALDH1A1
SCHEMBL7149094 0.76 GRM4 (0.55) ADORA2AADORA1ADORA2BADORA3ALDH1A1
SCHEMBL7150134 0.76 ADORA2A (0.50) ADORA2AADORA1ADORA2BADORA3ALDH1A1
SCHEMBL5040049 0.75 ADORA2A (0.44) ADORA2AADORA1ADORA2BADORA3ALDH1A1
SCHEMBL5040047 0.75 ADORA2A (0.44) ADORA2AADORA1ADORA2BADORA3ALDH1A1
SCHEMBL30353576 0.73 ALDH1A1 (0.58) ADORA2AADORA1ADORA2BADORA3ALDH1A1
SCHEMBL5040203 0.73 ADORA2A (0.57) ADORA2AADORA1ADORA2BADORA3ALDH1A1
SCHEMBL5040202 0.73 ADORA2A (0.57) ADORA2AADORA1ADORA2BADORA3ALDH1A1
SCHEMBL7146951 0.72 ADORA2A (0.55) ADORA2AADORA1ADORA2BADORA3ALDH1A1
SCHEMBL1554000 0.72 MAPT (0.58) ADORA2AADORA1ADORA2BADORA3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6586441-B2 2-Amino-6-benzylsulfanyl-4-thiophen-2-yl-pyridine-3,5-dicarbo -nitrile as an examplary preferred compound; Alzheimer's and Parkinson's diseases; neuroprotectors; schizophrenia, analgesics; anxiolytic agents; respiratory disorders HOFFMAN-LA ROCHE INC. 2003-07-01 US disclosed